Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma

Bibliographic Details
Title: Conversion to supportive care with biosimilar pegfilgrastim-cbqv enables budget-neutral expanded access to R-CHOP treatment in non-Hodgkin lymphoma
Authors: McBride, Ali, MacDonald, Karen, Abraham, Ivo *
Source: In Leukemia Research July 2021 106
Database: ScienceDirect
More Details
ISSN:01452126
DOI:10.1016/j.leukres.2021.106591
Published in:Leukemia Research
Language:English